KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Equity (2016 - 2025)

Historic Return on Equity for Jazz Pharmaceuticals (JAZZ) over the last 15 years, with Q3 2025 value amounting to 0.07%.

  • Jazz Pharmaceuticals' Return on Equity fell 1900.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year decrease of 1900.0%. This contributed to the annual value of 0.14% for FY2024, which is 200.0% up from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Return on Equity is 0.07%, which was down 1900.0% from 0.08% recorded in Q2 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Return on Equity peaked at 0.14% during Q1 2025, and registered a low of 0.12% during Q1 2022.
  • In the last 5 years, Jazz Pharmaceuticals' Return on Equity had a median value of 0.0% in 2022 and averaged 0.02%.
  • In the last 5 years, Jazz Pharmaceuticals' Return on Equity crashed by -2600bps in 2022 and then surged by 1900bps in 2023.
  • Jazz Pharmaceuticals' Return on Equity (Quarter) stood at 0.08% in 2021, then increased by 12bps to 0.07% in 2022, then soared by 257bps to 0.12% in 2023, then grew by 18bps to 0.14% in 2024, then crashed by -153bps to 0.07% in 2025.
  • Its Return on Equity stands at 0.07% for Q3 2025, versus 0.08% for Q2 2025 and 0.14% for Q1 2025.